Search results (42)
« Back to PublicationsModelling Country-Level Trajectories of Antimicrobial Resistance in Human Populations
Preprint
Srimokla O. et al, (2025)
Using routinely collected data to inform infection-prevention policy decisions
Thesis / Dissertation
Pritchard MG., (2025)
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Journal article
Citarella BW. et al, (2024), Heliyon, 10
Natural immune boosting leads to synchrony in immunity and cyclic outbreaks of disease for pathogens with rapidly waning immunity
Conference paper
Pritchard M. et al, (2023)
Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity
Preprint
Pritchard MG. et al, (2023)
The burden and dynamics of hospital-acquired SARS-CoV-2 in England.
Journal article
Cooper BS. et al, (2023), Nature, 623, 132 - 138
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
Journal article
Kartsonaki C. et al, (2023), Int J Epidemiol, 52, 355 - 376
Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients.
Journal article
Baruch J. et al, (2022), Influenza Other Respir Viruses, 16, 1040 - 1050
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Journal article
Gonçalves BP. et al, (2022), Elife, 11
Symptom-based case definitions for COVID-19: time and geographical variations for detection at hospital admission among 260,000 patients
Preprint
Group ISARICCC. et al, (2022)
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol.
Journal article
Knight SR. et al, (2022), Thorax, 77, 606 - 615
The value of open-source clinical science in pandemic response: lessons from ISARIC.
Journal article
ISARIC Clinical Characterisation Group ., (2021), Lancet Infect Dis, 21, 1623 - 1624
